Wound Administration of M2-Polarized Macrophages Does Not Improve Murine Cutaneous Healing Responses

Macrophages play a crucial role in all stages of cutaneous wound healing responses and dysregulation of macrophage function can result in derailed wound repair. The phenotype of macrophages is influenced by the wound microenvironment and evolves during healing from a more pro-inflammatory (M1) profile in early stages, to a less inflammatory pro-healing (M2) phenotype in later stages of repair. The aim of the current study was to investigate the potential of exogenous administration of M2 macrophages to promote wound healing in an experimental mouse model of cutaneous injury. Bone marrow derived macrophages were stimulated in-vitro with IL-4 or IL-10 to obtain two different subsets of M2-polarized cells, M2a or M2c respectively. Polarized macrophages were injected into full-thickness excisional skin wounds of either C57BL/6 or diabetic db/db mice. Control groups were injected with non-polarized (M0) macrophages or saline. Our data indicate that despite M2 macrophages exhibit an anti-inflammatory phenotype in-vitro, they do not improve wound closure in wild type mice while they delay healing in diabetic mice. Examination of wounds on day 15 post-injury indicated delayed re-epithelialization and persistence of neutrophils in M2 macrophage treated diabetic wounds. Therefore, topical application of ex-vivo generated M2 macrophages is not beneficial and contraindicated for cell therapy of skin wounds.

[1]  A. Wagenaar,et al.  Local Delivery of Polarized Macrophages Improves Reperfusion Recovery in a Mouse Hind Limb Ischemia Model , 2013, PloS one.

[2]  T. Koh,et al.  Blocking Interleukin-1β Induces a Healing-Associated Wound Macrophage Phenotype and Improves Healing in Type 2 Diabetes , 2013, Diabetes.

[3]  Wei-Chun Huang,et al.  Classical Macrophage Activation Up-Regulates Several Matrix Metalloproteinases through Mitogen Activated Protein Kinases and Nuclear Factor-κB , 2012, PloS one.

[4]  H. Sorg,et al.  Wound Repair and Regeneration , 2012, European Surgical Research.

[5]  D. Holmberg,et al.  Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice , 2012, Diabetes.

[6]  T. Koh,et al.  Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice. , 2011, Cytokine.

[7]  D. Greiner,et al.  Rapid Recruitment and Activation of Macrophages by Anti-Gal/α-Gal Liposome Interaction Accelerates Wound Healing , 2011, The Journal of Immunology.

[8]  Cord Sunderkötter,et al.  An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. , 2011, The Journal of clinical investigation.

[9]  D. Hume,et al.  An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. , 2010, Blood.

[10]  Werner Müller,et al.  Differential Roles of Macrophages in Diverse Phases of Skin Repair , 2010, The Journal of Immunology.

[11]  D. McKay,et al.  In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. , 2010, Gastroenterology.

[12]  E. Collard,et al.  Macrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice , 2010, PloS one.

[13]  J. Albina,et al.  The phenotype of murine wound macrophages , 2010, Journal of leukocyte biology.

[14]  Chawnshang Chang,et al.  Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. , 2009, The Journal of clinical investigation.

[15]  T. Koh,et al.  Selective and specific macrophage ablation is detrimental to wound healing in mice. , 2009, The American journal of pathology.

[16]  Wei Xu,et al.  Differential Macrophage Polarization in Male and Female BALB/c Mice Infected With Coxsackievirus B3 Defines Susceptibility to Viral Myocarditis , 2009, Circulation research.

[17]  P. Libby,et al.  Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.

[18]  A. Waisman,et al.  A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. , 2009, The American journal of pathology.

[19]  S. Saika,et al.  Impaired cutaneous wound healing with excess granulation tissue formation in TNFα-null mice , 2009, Archives of Dermatological Research.

[20]  Y. Hérault,et al.  Heme Oxygenase-1 Accelerates Cutaneous Wound Healing in Mice , 2009, PloS one.

[21]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[22]  H. Mühl,et al.  Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. , 2007, The Journal of investigative dermatology.

[23]  S. Youssef,et al.  Type II monocytes modulate T cell–mediated central nervous system autoimmune disease , 2007, Nature Medicine.

[24]  Y. Wang,et al.  Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. , 2007, Kidney international.

[25]  T. Krieg,et al.  Inflammation in wound repair: molecular and cellular mechanisms. , 2007, The Journal of investigative dermatology.

[26]  M. Giel-Moloney,et al.  Ubiquitous and uniform in vivo fluorescence in ROSA26‐EGFP BAC transgenic mice , 2007, Genesis.

[27]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[28]  A. Roberts,et al.  Full‐thickness wounding of the mouse tail as a model for delayed wound healing: accelerated wound closure in Smad3 knock‐out mice , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[29]  Matthijs Kramer,et al.  Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. DiPietro,et al.  Accelerated wound closure in neutrophil‐depleted mice , 2003, Journal of leukocyte biology.

[31]  U. Mirastschijski,et al.  Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds * , 2001, Experimental dermatology.

[32]  J. Pfeilschifter,et al.  Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. , 2000, The Journal of investigative dermatology.

[33]  E. Shinar,et al.  Treatment of human ulcers by application of macrophages prepared from a blood unit , 1997, Experimental Gerontology.

[34]  D. Greenhalgh,et al.  PDGF and FGF stimulate wound healing in the genetically diabetic mouse. , 1990, The American journal of pathology.

[35]  S. Verbruggen,et al.  Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo , 2013, Angiogenesis.

[36]  W. Jahnen-Dechent,et al.  Embryonic stem cell–derived M2‐like macrophages delay cutaneous wound healing , 2013, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[37]  G. Ashcroft,et al.  Tumor necrosis factor‐alpha (TNF‐α) is a therapeutic target for impaired cutaneous wound healing , 2012, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[38]  J. Albina,et al.  Wound macrophages as key regulators of repair: origin, phenotype, and function. , 2011, The American journal of pathology.

[39]  M. Karsdal,et al.  Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo. , 2002, The Journal of investigative dermatology.

[40]  E. Kovacs,et al.  Modulation of JE/MCP-1 expression in dermal wound repair. , 1995, The American journal of pathology.